TWC
DFTX

TD Waterhouse Canada’s Definium Therapeutics DFTX Stock Holding History

TD Waterhouse Canada’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.1K Buy
1,802
+270
+18% +$4.58K ﹤0.01% 1434
2025
Q4 		$20.5K Sell
1,532
-4,062
-73% -$50.3K ﹤0.01% 1388
2025
Q3 		$69.1K Sell
5,594
-63
-1% -$588 ﹤0.01% 1117
2025
Q2 		$37.7K Buy
5,657
+661
+13% +$4.35K ﹤0.01% 1187
2025
Q1 		$27.5K Buy
4,996
+661
+15% +$4.73K ﹤0.01% 1205
2024
Q4 		$30.1K Hold
4,335
– – ﹤0.01% 1192
2024
Q3 		$24.3K Sell
4,335
-163
-4% -$1.13K ﹤0.01% 1198
2024
Q2 		$32K Sell
4,498
-39
-0.9% -$341 ﹤0.01% 1127
2024
Q1 		$59.9K Buy
4,537
+3,880
+591% +$22.1K ﹤0.01% 1001
2023
Q4 		$2.92K Sell
657
-110
-14% -$331 ﹤0.01% 1451
2023
Q3 		$2.7K Sell
767
-1,030
-57% -$4.23K ﹤0.01% 1461
2023
Q2 		$7.92K Buy
1,797
+1,062
+144% +$3.66K ﹤0.01% 1297
2023
Q1 		$2.54K Sell
735
-293
-29% -$974 ﹤0.01% 1487
2022
Q4 		$3.06K Buy
1,028
+373
+57% +$1.04K ﹤0.01% 1432
2022
Q3 		$2.44K Buy
655
+145
+28% +$1.39K ﹤0.01% 1478
2022
Q2 		$5.2K Sell
510
-160
-24% -$2.02K ﹤0.01% 1386
2022
Q1 		$12.4K Sell
670
-223
-25% -$3.87K ﹤0.01% 1274
2021
Q4 		$21.8K Buy
+893
New +$28.5K ﹤0.01% 1185

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TD Waterhouse Canada's DFTX Position: Q1 2026 in Review

TD Waterhouse Canada increased its Definium Therapeutics (DFTX) stake by 18% in Q1 2026, buying an estimated $4.58K and bringing the position to 1,802 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1434.

TD Waterhouse Canada first reported a position in DFTX in Q4 2021 and has held it in 18 quarters since. The position peaked at $69.1K in Q3 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • TD Waterhouse Canada held 1,802 shares of Definium Therapeutics worth $37.1K as of Q1 2026.
  • TD Waterhouse Canada bought 270 Definium Therapeutics shares in Q1 2026, an estimated $4.58K.
  • Definium Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #1434 holding.
  • TD Waterhouse Canada first reported a position in Definium Therapeutics in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Definium Therapeutics position peaked at $69.1K in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.